Peter Lin MD, CCFP
Director, Primary Care Initiatives, Canadian Heart Research Centre, North York, OntarioDr. Peter Lin, a primary care physician, is the Director of Primary Care Initiatives at the Canadian Heart Research Centre and has two busy family medicine practices in Toronto. For 7 years, he served as the medical director at the University of Toronto Scarborough Health & Wellness Centre. In 2011, he received a teaching award from the College of Family Physicians of Canada.
Dr. Lin has worked with KDIGO (Kidney Disease│Improving Global Outcomes) in an effort to help enhance care for patients with chronic kidney disease. He has been a contributing author to the Canadian Diabetes Guidelines and has served on the editorial board of Pri-Med Institute, which provides education for physicians.
Dr. Lin maintains an active lecture schedule, reflecting his varied medical interests, continuing his focus on bridging the chasm between research and clinical practice.
Disclosures
- Consultant (continuing medical education programs): AstraZeneca; Boehringer Ingelheim; Bayer; Eli Lilly; Amgen; Janssen; Merck; Pfizer; Sanofi; Abbott; HLS Therapeutics
Recent Contributions to PracticeUpdate:
- Epidemiological Ramifications of Diagnosing Diabetes With HbA1c Levels
- Empagliflozin Effective, Safe With Insulin for Inadequately Controlled Diabetes
- The Child or Adolescent With Elevated Blood Pressure
- Risks Linked to Systolic and Diastolic Hypertension Are Age-Dependent
- Statin Use Linked to Lower Physical Activity in Older Men
- Diagnosis and Management of Resistant Hypertension
- Optimal Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation
- Hypoglycemia Edges Out Hyperglycemia in Hospital Admissions for Diabetes
- Physical Therapy for Hip Osteoarthritis
- 5-Year Survival After Acute Myocardial Infarction With Angiotensin-Converting Enzyme Inhibitors vs Angiotensin II Receptor Blockers